{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:22:12Z","timestamp":1787890932472,"version":"build-2784847793"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"USAID","award":["#7200AA22CA00002"],"award-info":[{"award-number":["#7200AA22CA00002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10461-024-04529-2","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:02:39Z","timestamp":1729242159000},"page":"257-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["HIV Prevention Product Acceptability and Preference Among Women in Sub-Saharan Africa to Inform Novel Biomedical Options in Development: A Systematic Review"],"prefix":"10.1007","volume":"29","author":[{"given":"Wanzirai","family":"Makoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Lorenzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Luecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhi","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini S.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Shoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Definate","family":"Nhamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis M.","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Baez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2943-2005","authenticated-orcid":false,"given":"Alexandra M.","family":"Minnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"4","key":"4529_CR1","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/S2352-3018(23)00026-7","volume":"10","author":"KM Williams","year":"2023","unstructured":"Williams KM, Miller N, Tutegyereize L, Olisa AL, Chakare T, Jeckonia P, et al. Defining principles for a choice-based approach to HIV prevention. Lancet HIV. 2023;10(4):e269\u201372.","journal-title":"Lancet HIV"},{"issue":"6","key":"4529_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/QAD.0000000000003494","volume":"37","author":"VA Fonner","year":"2023","unstructured":"Fonner VA, Ridgeway K, van der Straten A, Lorenzetti L, Dinh N, Rodolph M, et al. Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition. AIDS. 2023;37(6):957\u201366.","journal-title":"AIDS"},{"issue":"12","key":"4529_CR3","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS (London, England). 2016;30(12):1973.","journal-title":"AIDS (London, England)"},{"issue":"11","key":"4529_CR4","doi-asserted-by":"publisher","first-page":"e25634","DOI":"10.1002\/jia2.25634","volume":"23","author":"ER Brown","year":"2020","unstructured":"Brown ER, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee-Philips T, et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. J Int AIDS Soc. 2020;23(11):e25634.","journal-title":"J Int AIDS Soc"},{"issue":"22","key":"4529_CR5","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"key":"4529_CR6","unstructured":"UNAIDS. HIV prevention choice manifesto for women and girls in Africa launched. 2023."},{"key":"4529_CR7","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2016.","edition":"2"},{"key":"4529_CR8","volume-title":"WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection. Geneva: World Health Organization; 2021."},{"key":"4529_CR9","unstructured":"World Health Organization. Guidelines on long-acting injectable cabotegravir for HIV prevention. Genva, Switzerland: World Health Organization. 2022 Contract No.: Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"2","key":"4529_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.9745\/GHSP-D-13-00010","volume":"1","author":"J Ross","year":"2013","unstructured":"Ross J, Stover J. Use of modern contraception increases when more methods become available: analysis of evidence from 1982\u20132009. Glob Health Sci Pract. 2013;1(2):203\u201312.","journal-title":"Glob Health Sci Pract"},{"issue":"5","key":"4529_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/13625187.2022.2096215","volume":"27","author":"P D\u2019Souza","year":"2022","unstructured":"D\u2019Souza P, Bailey JV, Stephenson J, Oliver S. Factors influencing contraception choice and use globally: a synthesis of systematic reviews. Eur J Contracept Reprod Health Care. 2022;27(5):364\u201372.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"82","key":"4529_CR12","doi-asserted-by":"publisher","first-page":"S222","DOI":"10.1097\/QAI.0000000000002215","volume":"1","author":"AM Minnis","year":"2019","unstructured":"Minnis AM, Montgomery ET, Napierala S, Browne EN, van der Straten A. Insights for implementation science from 2 multiphased studies with end-users of potential multipurpose prevention technology and HIV prevention products. JAIDS J Acquir Immune Defic Syndr. 2019;1(82):S222\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"6","key":"4529_CR13","doi-asserted-by":"publisher","first-page":"e0287525","DOI":"10.1371\/journal.pone.0287525","volume":"18","author":"K Ngure","year":"2023","unstructured":"Ngure K, Friedland BA, Szydlo DW, Roberts ST, Garcia M, Levy L, et al. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034\/IPM-045 study). PLoS ONE. 2023;18(6):e0287525.","journal-title":"PLoS ONE"},{"issue":"6","key":"4529_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/COH.0b013e3283590632","volume":"7","author":"BS Mensch","year":"2012","unstructured":"Mensch BS, van der Straten A, Katzen LL. Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS. 2012;7(6):534\u201341.","journal-title":"Curr Opin HIV AIDS"},{"key":"4529_CR15","doi-asserted-by":"publisher","first-page":"682689","DOI":"10.3389\/frph.2021.682689","volume":"3","author":"BA Friedland","year":"2021","unstructured":"Friedland BA, Mathur S, Haddad LB. The promise of the dual prevention pill: a framework for development and introduction. Front Reprod Health. 2021;3:682689.","journal-title":"Front Reprod Health"},{"issue":"2","key":"4529_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s10461-022-03796-1","volume":"27","author":"KF Ortblad","year":"2023","unstructured":"Ortblad KF, Sekhon M, Wang L, Roth S, van der Straten A, Simoni JM, et al. Acceptability assessment in HIV prevention and treatment intervention and service delivery research: a systematic review and qualitative analysis. AIDS Behav. 2023;27(2):600\u201317.","journal-title":"AIDS Behav"},{"issue":"2","key":"4529_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10461-013-0560-7","volume":"18","author":"I Young","year":"2014","unstructured":"Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195\u2013216.","journal-title":"AIDS Behav"},{"key":"4529_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.contraception.2021.10.001","volume":"106","author":"K Ridgeway","year":"2022","unstructured":"Ridgeway K, Montgomery ET, Smith K, Torjesen K, van der Straten A, Achilles SL, et al. Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception. 2022;106:16\u201333.","journal-title":"Contraception"},{"issue":"Suppl 2","key":"4529_CR19","doi-asserted-by":"publisher","first-page":"e26107","DOI":"10.1002\/jia2.26107","volume":"26","author":"L Lorenzetti","year":"2023","unstructured":"Lorenzetti L, Dinh N, van der Straten A, Fonner V, Ridgeway K, Rodolph M, et al. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition. J Int AIDS Soc. 2023;26(Suppl 2):e26107.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"4529_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-34.","journal-title":"J Clin Epidemiol"},{"issue":"92","key":"4529_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.addr.2015.02.004","volume":"15","author":"C Woodsong","year":"2015","unstructured":"Woodsong C, Holt JD. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy. Adv Drug Deliv Rev. 2015;15(92):146\u201354.","journal-title":"Adv Drug Deliv Rev"},{"key":"4529_CR22","first-page":"187","volume-title":"Vasta. six theories of child development: revised formulations and current issues","author":"U Bronfenbrenner","year":"1989","unstructured":"Bronfenbrenner U. Ecological systems theory. In: Vasta. six theories of child development: revised formulations and current issues. Washington: American Psychological Association; 1989. p. 187\u2013249."},{"issue":"5","key":"4529_CR23","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","volume":"21","author":"KR Amico","year":"2017","unstructured":"Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, et al. Experiences with HPTN 067\/ADAPT study-provided open-label PrEP among women in Cape Town: facilitators and barriers within a mutuality framework. AIDS Behav. 2017;21(5):1361\u201375.","journal-title":"AIDS Behav"},{"issue":"2","key":"4529_CR24","doi-asserted-by":"publisher","first-page":"e0191251","DOI":"10.1371\/journal.pone.0191251","volume":"13","author":"M Atujuna","year":"2018","unstructured":"Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, et al. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: a qualitative study. PLoS ONE. 2018;13(2):e0191251.","journal-title":"PLoS ONE"},{"issue":"3","key":"4529_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/09540121.2017.1363369","volume":"30","author":"AR Bazzi","year":"2018","unstructured":"Bazzi AR, Yotebieng KA, Agot K, Rota G, Syvertsen JL. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya. AIDS Care. 2018;30(3):343\u20136.","journal-title":"AIDS Care"},{"issue":"8","key":"4529_CR26","doi-asserted-by":"publisher","first-page":"e058611","DOI":"10.1136\/bmjopen-2021-058611","volume":"12","author":"SW Beckham","year":"2022","unstructured":"Beckham SW, Mantsios A, Galai N, Likindikoki S, Mbwambo J, Davis W, et al. Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study. BMJ Open. 2022;12(8):e058611.","journal-title":"BMJ Open"},{"issue":"10","key":"4529_CR27","doi-asserted-by":"publisher","first-page":"e26024","DOI":"10.1002\/jia2.26024","volume":"25","author":"NL Bhushan","year":"2022","unstructured":"Bhushan NL, Musara P, Hartmann M, Stoner MCD, Shah SR, Nabukeera J, et al. Making the case for joint decision-making in future multipurpose prevention technology (MPT) choice: qualitative findings on MPT attribute preferences from the CUPID study (MTN-045). J Int AIDS Soc. 2022;25(10):e26024.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4529_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1186\/s12889-021-10766-0","volume":"21","author":"PJ Bjertrup","year":"2021","unstructured":"Bjertrup PJ, Mmema N, Dlamini V, Ciglenecki I, Mpala Q, Matse S, et al. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini. BMC Public Health. 2021;21(1):727.","journal-title":"BMC Public Health"},{"issue":"6","key":"4529_CR29","doi-asserted-by":"publisher","first-page":"e1003670","DOI":"10.1371\/journal.pmed.1003670","volume":"18","author":"C Celum","year":"2021","unstructured":"Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, et al. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLoS Med. 2021;18(6):e1003670.","journal-title":"PLoS Med"},{"issue":"2","key":"4529_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/09540121.2021.1902933","volume":"34","author":"N Chimbindi","year":"2022","unstructured":"Chimbindi N, Mthiyane N, Zuma T, Baisley K, Pillay D, McGrath N, et al. Antiretroviral therapy based HIV prevention targeting young women who sell sex: a mixed method approach to understand the implementation of PrEP in a rural area of KwaZulu-Natal, South Africa. AIDS Care. 2022;34(2):232\u201340.","journal-title":"AIDS Care"},{"issue":"4","key":"4529_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/QAI.0000000000000880","volume":"71","author":"A Corneli","year":"2016","unstructured":"Corneli A, Perry B, McKenna K, Agot K, Ahmed K, Taylor J, et al. Participants\u2019 explanations for nonadherence in the FEM-PrEP clinical trial. J Acquir Immune Defic Syndr. 2016;71(4):452\u201361.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4529_CR32","doi-asserted-by":"publisher","first-page":"e0212271","DOI":"10.1371\/journal.pone.0212271","volume":"14","author":"R Eakle","year":"2019","unstructured":"Eakle R, Bothma R, Bourne A, Gumede S, Motsosi K, Rees H. \u201cI am still negative\u201d: female sex workers\u2019 perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa. PLoS ONE. 2019;14(4):e0212271.","journal-title":"PLoS ONE"},{"issue":"2","key":"4529_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jia2.25081","volume":"21","author":"R Eakle","year":"2018","unstructured":"Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa. J Int AIDS Soc. 2018;21(2):1.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4529_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12889-020-8195-x","volume":"20","author":"G Emmanuel","year":"2020","unstructured":"Emmanuel G, Folayan M, Undelikwe G, Ochonye B, Jayeoba T, Yusuf A, et al. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria. BMC Public Health. 2020;20(1):69.","journal-title":"BMC Public Health"},{"issue":"1","key":"4529_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/apc.2014.0210","volume":"29","author":"N Fowler","year":"2015","unstructured":"Fowler N, Arkell P, Abouyannis M, James C, Roberts L. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study. AIDS Patient Care STDS. 2015;29(1):33\u201342.","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"4529_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2352-4642(20)30248-0","volume":"4","author":"K Gill","year":"2020","unstructured":"Gill K, Johnson L, Dietrich J, Myer L, Marcus R, Wallace M, et al. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial. Lancet Child Adolesc Health. 2020;4(12):875\u201383.","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"4529_CR37","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s10508-021-02052-2","volume":"50","author":"D Giovenco","year":"2021","unstructured":"Giovenco D, Kuo C, Underhill K, Hoare J, Operario D. Adolescent-centered HIV prevention: perspectives on acceptability of oral antiretroviral pre-exposure prophylaxis for adolescents in a global priority setting. Arch Sex Behav. 2021;50(7):2921\u201331.","journal-title":"Arch Sex Behav"},{"issue":"1","key":"4529_CR38","doi-asserted-by":"publisher","first-page":"e0227632","DOI":"10.1371\/journal.pone.0227632","volume":"15","author":"MM Gombe","year":"2020","unstructured":"Gombe MM, Cakouros BE, Ncube G, Zwangobani N, Mareke P, Mkwamba A, et al. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: qualitative perspectives of general population clients at high risk for HIV. PLoS ONE. 2020;15(1):e0227632.","journal-title":"PLoS ONE"},{"issue":"10","key":"4529_CR39","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/09540121.2018.1488027","volume":"30","author":"E Govender","year":"2018","unstructured":"Govender E, Abdool KQ. Understanding women and men\u2019s acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa. AIDS Care. 2018;30(10):1311\u20134.","journal-title":"AIDS Care"},{"issue":"10","key":"4529_CR40","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1007\/s10461-022-03646-0","volume":"26","author":"M Inghels","year":"2022","unstructured":"Inghels M, Kim HY, Tanser F, Hettema A, McMahon SA, Oldenburg CE, et al. PrEP uptake and delivery setting preferences among clients visiting six healthcare facilities in Eswatini. AIDS Behav. 2022;26(10):3345\u201355.","journal-title":"AIDS Behav"},{"issue":"8","key":"4529_CR41","doi-asserted-by":"publisher","first-page":"e25588","DOI":"10.1002\/jia2.25588","volume":"23","author":"J Kagaayi","year":"2020","unstructured":"Kagaayi J, Batte J, Nakawooya H, Kigozi B, Nakigozi G, Str\u00f6mdahl S, et al. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda. J Int AIDS Soc. 2020;23(8):e25588.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4529_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2989\/16085906.2022.2039727","volume":"21","author":"R Kawuma","year":"2022","unstructured":"Kawuma R, Nabalwanyi Z, Seeley J, Mayanja Y. \u201cI prefer to take pills when I plan to have sex\u201d: perceptions of on-demand versus daily oral pre-exposure prophylaxis among adolescents in Kampala. Uganda Afr J AIDS Res. 2022;21(1):8\u201314.","journal-title":"Uganda Afr J AIDS Res"},{"issue":"5","key":"4529_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s10461-014-0891-z","volume":"19","author":"PM Kebaabetswe","year":"2015","unstructured":"Kebaabetswe PM, Stirratt MJ, McLellan-Lemal E, Henderson FL, Gray SC, Rose CE, et al. Factors associated with adherence and concordance between measurement strategies in an HIV daily oral tenofovir\/emtricitibine as pre-exposure prophylaxis (Prep) clinical trial, Botswana, 2007\u20132010. AIDS Behav. 2015;19(5):758\u201369.","journal-title":"AIDS Behav"},{"issue":"sup2","key":"4529_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/09540121.2020.1742861","volume":"32","author":"R Kidman","year":"2020","unstructured":"Kidman R, Nachman S, Kohler HP. Interest in HIV pre-exposure prophylaxis (PrEP) among adolescents and their caregivers in Malawi. AIDS Care. 2020;32(sup2):23\u201331.","journal-title":"AIDS Care"},{"issue":"10","key":"4529_CR45","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1007\/s10461-019-02418-7","volume":"23","author":"MO Kuteesa","year":"2019","unstructured":"Kuteesa MO, Quaife M, Biraro S, Katumba KR, Seeley J, Kamali A, et al. Acceptability and predictors of uptake of anti-retroviral pre-exposure prophylaxis (PrEP) among fishing communities in Uganda: a cross-sectional discrete choice experiment survey. AIDS Behav. 2019;23(10):2674\u201386.","journal-title":"AIDS Behav"},{"issue":"4","key":"4529_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/QAI.0000000000001518","volume":"76","author":"M Lahuerta","year":"2017","unstructured":"Lahuerta M, Zerbe A, Baggaley R, Falcao J, Ahoua L, DiMattei P, et al. Feasibility, acceptability, and adherence with short-term HIV preexposure prophylaxis in female sexual partners of migrant miners in Mozambique. J Acquir Immune Defic Syndr. 2017;76(4):343\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"4529_CR47","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10461-019-02705-3","volume":"24","author":"KE Lancaster","year":"2020","unstructured":"Lancaster KE, Lungu T, Bula A, Shea JM, Shoben A, Hosseinipour MC, et al. Preferences for pre-exposure prophylaxis service delivery among female sex workers in Malawi: a discrete choice experiment. AIDS Behav. 2020;24(5):1294\u2013303.","journal-title":"AIDS Behav"},{"issue":"9","key":"4529_CR48","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s10461-022-03658-w","volume":"26","author":"KM Little","year":"2022","unstructured":"Little KM, Flomen L, Hanif H, Anderson SM, Thurman AR, Clark MR, et al. HIV pre-exposure prophylaxis implant stated preferences and priorities: results of a discrete choice experiment among women and adolescent girls in Gauteng Province, South Africa. AIDS Behav. 2022;26(9):3099\u2013109.","journal-title":"AIDS Behav"},{"issue":"1","key":"4529_CR49","doi-asserted-by":"publisher","first-page":"20875","DOI":"10.7448\/IAS.19.1.20875","volume":"19","author":"EH Luecke","year":"2016","unstructured":"Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study. J Int AIDS Soc. 2016;19(1):20875.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"4529_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2989\/16085906.2020.1727932","volume":"19","author":"L Mbewe","year":"2020","unstructured":"Mbewe L, Govender E. Male partners\u2019 influence on women\u2019s acceptance and use of PrEP products across two high HIV-burdened districts in South Africa. Afr J AIDS Res. 2020;19(2):93\u2013100.","journal-title":"Afr J AIDS Res"},{"issue":"4","key":"4529_CR51","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/QAI.0000000000001945","volume":"80","author":"AM Minnis","year":"2019","unstructured":"Minnis AM, Browne EN, Boeri M, Agot K, van der Straten A, Ahmed K, et al. Young women\u2019s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019;80(4):394\u2013403.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4529_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10461-022-03713-6","volume":"8","author":"AM Minnis","year":"2022","unstructured":"Minnis AM, Etima J, Musara P, Browne EN, Mutero P, Kemigisha D, et al. Couples\u2019 Preferences for \u201c2 in 1\u201d multipurpose prevention technologies to prevent both HIV and pregnancy: results of a discrete choice experiment in Uganda and Zimbabwe. AIDS Behav. 2022;8:1\u201314. https:\/\/doi.org\/10.1007\/s10461-022-03713-6.","journal-title":"AIDS Behav"},{"issue":"1","key":"4529_CR53","first-page":"1927477","volume":"29","author":"AM Minnis","year":"2021","unstructured":"Minnis AM, Krogstad E, Shapley-Quinn MK, Agot K, Ahmed K, Danielle Wagner L, et al. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa. Sex Reprod Health Matters. 2021;29(1):1927477.","journal-title":"Sex Reprod Health Matters"},{"issue":"8","key":"4529_CR54","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1007\/s10461-018-2078-5","volume":"22","author":"AM Minnis","year":"2018","unstructured":"Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, et al. Young women\u2019s ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS Behav. 2018;22(8):2662\u201373.","journal-title":"AIDS Behav"},{"issue":"5","key":"4529_CR55","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/QAI.0000000000001960","volume":"80","author":"ET Montgomery","year":"2019","unstructured":"Montgomery ET, Atujuna M, Krogstad E, Hartmann M, Ndwayana S, O\u2019Rourke S, et al. The invisible product: preferences for sustained-release, long-acting pre-exposure prophylaxis to HIV among South African youth. J Acquir Immune Defic Syndr. 2019;80(5):542\u201350.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"4529_CR56","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10461-014-0950-5","volume":"19","author":"ET Montgomery","year":"2015","unstructured":"Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, et al. Male partner influence on women\u2019s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of \u201cUnderstanding.\u201d AIDS Behav. 2015;19(5):784\u201393.","journal-title":"AIDS Behav"},{"key":"4529_CR57","doi-asserted-by":"publisher","DOI":"10.4102\/sajhivmed.v21i1.1039","author":"T Mudzviti","year":"2020","unstructured":"Mudzviti T, Dhliwayo A, Chingombe B, Ngara B, Monera-Penduka TG, Maponga CC, et al. Perspectives on oral pre-exposure prophylaxis use amongst female sex workers in Harare, Zimbabwe. South Afr J HIV Med. 2020. https:\/\/doi.org\/10.4102\/sajhivmed.v21i1.1039.","journal-title":"South Afr J HIV Med"},{"issue":"4","key":"4529_CR58","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10508-020-01880-y","volume":"50","author":"R Muhumuza","year":"2021","unstructured":"Muhumuza R, Ssemata AS, Kakande A, Ahmed N, Atujuna M, Nomvuyo M, et al. Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa. Arch Sex Behav. 2021;50(4):1729\u201342.","journal-title":"Arch Sex Behav"},{"issue":"7","key":"4529_CR59","doi-asserted-by":"publisher","first-page":"e0271104","DOI":"10.1371\/journal.pone.0271104","volume":"17","author":"S Nakamanya","year":"2022","unstructured":"Nakamanya S, Kawuma R, Kibuuka D, Kusemererwa S, McCormack S, Ruzagira E, et al. Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda. PLoS ONE. 2022;17(7):e0271104.","journal-title":"PLoS ONE"},{"issue":"9","key":"4529_CR60","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/13691058.2016.1164899","volume":"18","author":"E Namey","year":"2016","unstructured":"Namey E, Agot K, Ahmed K, Odhiambo J, Skhosana J, Guest G, et al. When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling. Cult Health Sex. 2016;18(9):1081\u201391.","journal-title":"Cult Health Sex"},{"issue":"1","key":"4529_CR61","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1186\/s12889-022-14236-z","volume":"22","author":"L Nyblade","year":"2022","unstructured":"Nyblade L, Ndirangu JW, Speizer IS, Browne FA, Bonner CP, Minnis A, et al. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa. BMC Public Health. 2022;22(1):1916.","journal-title":"BMC Public Health"},{"issue":"1","key":"4529_CR62","doi-asserted-by":"publisher","first-page":"E150","DOI":"10.1097\/QAI.0000000000002625","volume":"87","author":"FK Ongolly","year":"2021","unstructured":"Ongolly FK, Dolla A, Ngure K, Irungu EM, Odoyo J, Wamoni E, et al. \u201cI Just Decided to Stop:\u201d understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya. J Acquir Immune Defic Syndr. 2021;87(1):E150\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"4529_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/QAI.0000000000001516","volume":"76","author":"J Pintye","year":"2017","unstructured":"Pintye J, Beima-Sofie KM, Kimemia G, Ngure K, Trinidad SB, Heffron RA, et al. \u201cI Did Not Want to Give Birth to a Child Who has HIV\u201d: experiences using PrEP during pregnancy among HIV-uninfected Kenyan women in HIV-serodiscordant couples. J Acquir Immune Defic Syndr. 2017;76(3):259\u201365.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"4529_CR64","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1089\/apc.2018.0058","volume":"32","author":"J Pintye","year":"2018","unstructured":"Pintye J, Beima-Sofie KM, Makabong\u2019O PA, Njoroge A, Trinidad SB, Heffron RA, et al. HIV-uninfected Kenyan adolescent and young women share perspectives on using preexposure prophylaxis during pregnancy. Aids Patient Care STDS. 2018;32(12):538\u201344.","journal-title":"Aids Patient Care STDS"},{"issue":"4","key":"4529_CR65","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1097\/QAI.0000000000002587","volume":"86","author":"J Pintye","year":"2021","unstructured":"Pintye J, O\u2019Malley G, Kinuthia J, Abuna F, Escudero JN, Mugambi M, et al. Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: a qualitative evaluation from a PrEP implementation program. J Acquir Immune Defic Syndr. 2021;86(4):e83\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4529_CR66","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0272989X17729376","volume":"38","author":"M Quaife","year":"2018","unstructured":"Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Kilbourne-Brook M, Mvundura M, et al. Divergent preferences for HIV prevention: a discrete choice experiment for multipurpose HIV prevention products in South Africa. Med Decis Mak. 2018;38(1):120\u201333.","journal-title":"Med Decis Mak"},{"issue":"2","key":"4529_CR67","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1521\/aeap.2017.29.2.141","volume":"29","author":"AJ Restar","year":"2017","unstructured":"Restar AJ, Tocco JU, Mantell JE, Lafort Y, Gichangi P, Masvawure TB, et al. Perspectives on HIV pre- and post-exposure prophylaxes (PrEP and PEP) among female and male sex workers in Mombasa, Kenya: implications for integrating biomedical prevention into sexual health services. AIDS Educ Prev. 2017;29(2):141\u201353.","journal-title":"AIDS Educ Prev"},{"issue":"3","key":"4529_CR68","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/QAI.0000000000001093","volume":"73","author":"ST Roberts","year":"2016","unstructured":"Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, et al. Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: a prospective cohort study. J Acquir Immune Defic Syndr. 2016;73(3):313\u201322.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"4529_CR69","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1177\/0956462420943704","volume":"31","author":"M Sarr","year":"2020","unstructured":"Sarr M, Gueye D, Mboup A, Diouf O, Bao MDB, Ndiaye AJ, et al. Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal. Int J STD AIDS. 2020;31(11):1063\u201372.","journal-title":"Int J STD AIDS"},{"issue":"11","key":"4529_CR70","doi-asserted-by":"publisher","first-page":"e0259779","DOI":"10.1371\/journal.pone.0259779","volume":"16","author":"M Sekhon","year":"2021","unstructured":"Sekhon M, van der Straten A. Pregnant and breastfeeding women\u2019s prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: a multisite qualitative analysis using the theoretical framework of acceptability. PLoS ONE. 2021;16(11):e0259779.","journal-title":"PLoS ONE"},{"issue":"1","key":"4529_CR71","doi-asserted-by":"publisher","first-page":"1886455","DOI":"10.1080\/16549716.2021.1886455","volume":"14","author":"S Shamu","year":"2021","unstructured":"Shamu S, Shamu P, Khupakonke S, Farirai T, Chidarikire T, Guloba G, et al. Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts. Glob Health Action. 2021;14(1):1886455.","journal-title":"Glob Health Action"},{"key":"4529_CR72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/IJWH.S185712","volume":"11","author":"MK Shapley-Quinn","year":"2019","unstructured":"Shapley-Quinn MK, Manenzhe KN, Agot K, Minnis AM, van der Straten A. \u201cWe are not the same\u201d: African women\u2019s view of multipurpose prevention products in the TRIO clinical study. Int J Womens Health. 2019;11:97\u2013107.","journal-title":"Int J Womens Health"},{"issue":"8","key":"4529_CR73","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/apc.2020.0037","volume":"34","author":"J Sila","year":"2020","unstructured":"Sila J, Larsen AM, Kinuthia J, Owiti G, Abuna F, Kohler PK, et al. High awareness, yet low uptake, of pre-exposure prophylaxis among adolescent girls and young women within family planning clinics in Kenya. AIDS Patient Care STDS. 2020;34(8):336\u201343.","journal-title":"AIDS Patient Care STDS"},{"key":"4529_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-020-00271-6","author":"K Sullivan","year":"2020","unstructured":"Sullivan K, Mtande T, Jaffe E, Rosenberg N, Zimba C, Hoffman I, et al. Views among Malawian women about joining HIV prevention clinical trials when pregnant. AIDS Res Ther. 2020. https:\/\/doi.org\/10.1186\/s12981-020-00271-6.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"4529_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12981-021-00343-1","volume":"18","author":"J Tubert","year":"2021","unstructured":"Tubert J, Packel L, Hunter LA, Mfaume R, Njau P, Ramadhani AA, et al. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania. AIDS Res Ther. 2021;18(1):21.","journal-title":"AIDS Res Ther"},{"issue":"3","key":"4529_CR76","doi-asserted-by":"publisher","first-page":"e25094","DOI":"10.1002\/jia2.25094","volume":"21","author":"A van der Straten","year":"2018","unstructured":"van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K, et al. The tablets, ring, injections as options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21(3):e25094.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"4529_CR77","doi-asserted-by":"publisher","first-page":"e25536","DOI":"10.1002\/jia2.25536","volume":"23","author":"A van der Straten","year":"2020","unstructured":"van der Straten A, Ryan JH, Reddy K, Etima J, Taulo F, Mutero P, et al. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study. J Int AIDS Soc. 2020;23(6):e25536.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"4529_CR78","doi-asserted-by":"publisher","first-page":"e0265303","DOI":"10.1371\/journal.pone.0265303","volume":"17","author":"LD Wagner","year":"2022","unstructured":"Wagner LD, Minnis AM, Shea J, Agot K, Ahmed K, van der Straten A. Female and male partner perspectives on placebo multipurpose prevention technologies (MPTs) used by women in the TRIO study in South Africa and Kenya. PLoS ONE. 2022;17(5):e0265303.","journal-title":"PLoS ONE"},{"issue":"1","key":"4529_CR79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10461-017-1911-6","volume":"22","author":"R Weinrib","year":"2018","unstructured":"Weinrib R, Minnis A, Agot K, Ahmed K, Owino F, Manenzhe K, et al. End-users\u2019 product preference across three multipurpose prevention technology delivery forms: baseline results from young women in Kenya and South Africa. AIDS Behav. 2018;22(1):133\u201345.","journal-title":"AIDS Behav"},{"key":"4529_CR80","doi-asserted-by":"publisher","first-page":"101278","DOI":"10.1016\/j.eclinm.2022.101278","volume":"44","author":"SS Witte","year":"2022","unstructured":"Witte SS, Filippone P, Ssewamala FM, Nabunya P, Bahar OS, Mayo-Wilson LJ, et al. PrEP acceptability and initiation among women engaged in sex work in Uganda: implications for HIV prevention. EClinicalMedicine. 2022;44:101278.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"4529_CR81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12879-022-07398-z","volume":"22","author":"JF Lunkuse","year":"2022","unstructured":"Lunkuse JF, Kamacooko O, Muturi-Kioi V, Chinyenze K, Kuteesa MO, Price MA, et al. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda. BMC Infect Dis. 2022;22(1):467.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4529_CR82","doi-asserted-by":"publisher","first-page":"e25909","DOI":"10.1002\/jia2.25909","volume":"25","author":"Y Mayanja","year":"2022","unstructured":"Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, et al. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study. J Int AIDS Soc. 2022;25(5):e25909.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"4529_CR83","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2989\/16085906.2022.2138474","volume":"21","author":"P Musara","year":"2022","unstructured":"Musara P, Hartmann M, Ryan JH, Reddy K, Ggita J, Mutero P, et al. Understanding the role of men in women\u2019s use of the vaginal ring and oral PrEP during pregnancy and breastfeeding: multi-stakeholder perspectives. Afr J AIDS Res. 2022;21(4):354\u201363.","journal-title":"Afr J AIDS Res"},{"issue":"8","key":"4529_CR84","first-page":"963","volume":"2","author":"ET Montgomery","year":"2023","unstructured":"Montgomery ET, Hawley I, Fairlie L, Bunge K, Mathebula F, Etima J, et al. Acceptability of the dapivirine vaginal ring and oral truvada among african users in late-stage of pregnancy. AIDS Behav. 2023;2(8):963.","journal-title":"AIDS Behav"},{"issue":"7","key":"4529_CR85","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/apc.2017.0075","volume":"31","author":"A van der Straten","year":"2017","unstructured":"van der Straten A, Shapley-Quinn MK, Reddy K, Cheng H, Etima J, Woeber K, et al. Favoring \u201cpeace of Mind\u201d: a qualitative study of African women\u2019s HIV prevention product formulation preferences from the MTN-020\/ASPIRE trial. AIDS Patient Care STDS. 2017;31(7):305\u201314.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"4529_CR86","doi-asserted-by":"publisher","first-page":"e25283","DOI":"10.1002\/jia2.25283","volume":"22","author":"ET Montgomery","year":"2019","unstructured":"Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, et al. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019;22(5):e25283.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"4529_CR87","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/09540121.2016.1248349","volume":"29","author":"EM Govender","year":"2017","unstructured":"Govender EM, Mansoor LE, Abdool KQ. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake. AIDS Care. 2017;29(6):734\u201340.","journal-title":"AIDS Care"},{"issue":"11","key":"4529_CR88","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1007\/s10461-016-1339-4","volume":"20","author":"KM MacQueen","year":"2016","unstructured":"MacQueen KM, Dlamini S, Perry B, Okumu E, Sortijas S, Singh C, et al. Social context of adherence in an open-label 1 % tenofovir gel trial: gender dynamics and disclosure in KwaZulu-Natal. South Africa AIDS and behavior. 2016;20(11):2682\u201391.","journal-title":"South Africa AIDS and behavior"},{"issue":"4","key":"4529_CR89","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/QAI.0000000000002463","volume":"85","author":"L Miller","year":"2020","unstructured":"Miller L, Morar N, Kapiga S, Ramjee G, Hayes R. Prevention, partners, and power imbalances: women\u2019s views on how male partners affected their adherence to vaginal microbicide gels during HIV prevention trials in Africa. J Acquir Immune Defic Syndr. 2020;85(4):458\u201365.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4529_CR90","doi-asserted-by":"publisher","first-page":"e0244652","DOI":"10.1371\/journal.pone.0244652","volume":"16","author":"L Miller","year":"2021","unstructured":"Miller L, Morar N, Kapiga S, Ramjee G, Hayes R. Women design their own vaginal microbicide trial: suggestions on how to improve adherence from former participants of HIV prevention trials. PLoS ONE. 2021;16(1):e0244652.","journal-title":"PLoS ONE"},{"issue":"1","key":"4529_CR91","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s10461-020-02949-4","volume":"25","author":"P Musara","year":"2021","unstructured":"Musara P, Milford C, Shapley-Quinn MK, Weinrib R, Mutero P, Odoom E, et al. Preferences and acceptability of vaginal delivery forms for HIV prevention among women, male partners and key informants in South Africa and Zimbabwe: qualitative findings. AIDS Behav. 2021;25(1):124\u201338.","journal-title":"AIDS Behav"},{"issue":"5","key":"4529_CR92","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/07399332.2017.1292277","volume":"38","author":"SR Schuler","year":"2017","unstructured":"Schuler SR, Bukusi E. Male engagement in women\u2019s microbicide use in Kenya: navigating gender norms. Health Care Women Int. 2017;38(5):507\u201319.","journal-title":"Health Care Women Int"},{"issue":"2","key":"4529_CR93","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10461-019-02576-8","volume":"24","author":"R Weinrib","year":"2020","unstructured":"Weinrib R, Browne EN, Shapley-Quinn MK, van der Straten A, Beksinska M, Mgodi N, et al. Perspectives from young South African and Zimbabwean women on attributes of four (placebo) vaginal microbicide delivery forms. AIDS Behav. 2020;24(2):637\u201347.","journal-title":"AIDS Behav"},{"issue":"5","key":"4529_CR94","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10461-019-02715-1","volume":"24","author":"EN Browne","year":"2020","unstructured":"Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, et al. Efficacy is not everything: eliciting women\u2019s preferences for a vaginal HIV prevention product using a discrete-choice experiment. AIDS Behav. 2020;24(5):1443\u201351.","journal-title":"AIDS Behav"},{"issue":"5","key":"4529_CR95","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/13625187.2019.1656188","volume":"24","author":"CW Hart","year":"2019","unstructured":"Hart CW, Joanis C, Hartmann M, Milford C, Smit J, Beksinska M, et al. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa. Eur J Contracept Reprod Health Care. 2019;24(5):390\u20138.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"10","key":"4529_CR96","doi-asserted-by":"publisher","first-page":"e0204821","DOI":"10.1371\/journal.pone.0204821","volume":"13","author":"ND Laborde","year":"2018","unstructured":"Laborde ND, Leslie J, Krogstad E, Morar N, Mutero P, Etima J, et al. Perceptions of the \u201cFabric\u201d\u2014an exploratory study of a novel multi-purpose technology among women in Sub Saharan Africa. PLoS ONE. 2018;13(10):e0204821.","journal-title":"PLoS ONE"},{"issue":"11","key":"4529_CR97","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/13691058.2018.1552989","volume":"21","author":"M Chitukuta","year":"2019","unstructured":"Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T, et al. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Cult Health Sex. 2019;21(11):1209\u201324.","journal-title":"Cult Health Sex"},{"issue":"2","key":"4529_CR98","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10461-019-02514-8","volume":"24","author":"Z Duby","year":"2020","unstructured":"Duby Z, Katz AWK, Browne EN, Mutero P, Etima J, Zimba CC, et al. Hygiene, blood flow, and vaginal overload: why women removed an HIV Prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020;24(2):617\u201328.","journal-title":"AIDS Behav"},{"issue":"1","key":"4529_CR99","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2989\/16085906.2020.1866043","volume":"20","author":"A Kabarambi","year":"2021","unstructured":"Kabarambi A, Kusemererwa S, Krogstad E, Mayaud P, Seeley J, Mugisha J, et al. The dapivirine vaginal ring from the perspective of married men in Uganda. Afr J AIDS Res. 2021;20(1):53\u201360.","journal-title":"Afr J AIDS Res"},{"issue":"12","key":"4529_CR100","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1007\/s10461-021-03338-1","volume":"25","author":"AWK Katz","year":"2021","unstructured":"Katz AWK, Mansoor LE, Tsidya M, Mathebula F, Singh D, Siva S, et al. Using emoji stickers to understand end-user opinions of the dapivirine vaginal ring for HIV prevention. AIDS Behav. 2021;25(12):3955\u201366.","journal-title":"AIDS Behav"},{"issue":"8","key":"4529_CR101","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s10461-020-02799-0","volume":"24","author":"AWK Katz","year":"2020","unstructured":"Katz AWK, Naidoo K, Reddy K, Chitukuta M, Nabukeera J, Siva S, et al. The power of the shared experience: MTN-020\/ASPIRE trial participants\u2019 descriptions of peer influence on acceptability of and adherence to the dapivirine vaginal ring for HIV prevention. AIDS Behav. 2020;24(8):2387\u201399.","journal-title":"AIDS Behav"},{"issue":"8","key":"4529_CR102","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1007\/s10461-021-03205-z","volume":"25","author":"AJ Mayo","year":"2021","unstructured":"Mayo AJ, Browne EN, Montgomery ET, Torjesen K, Palanee-Phillips T, Jeenarain N, et al. Acceptability of the dapivirine vaginal ring for HIV-1 prevention and association with adherence in a phase III trial. AIDS Behav. 2021;25(8):2430\u201340.","journal-title":"AIDS Behav"},{"key":"4529_CR103","doi-asserted-by":"publisher","first-page":"106935","DOI":"10.1016\/j.cct.2022.106935","volume":"122","author":"E McLellan-Lemal","year":"2022","unstructured":"McLellan-Lemal E, Deaton SR, Betts JE, Ondenge K, Mudhune V, O\u2019Connor SM, et al. Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: qualitative findings of the Kisumu combined ring study, 2019. Contemp Clin Trials. 2022;122:106935.","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"4529_CR104","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/QAD.0000000000001868","volume":"32","author":"ET Montgomery","year":"2018","unstructured":"Montgomery ET, Stadler J, Naidoo S, Katz AWK, Laborde N, Garcia M, et al. Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS. 2018;32(11):1517\u201325.","journal-title":"AIDS"},{"issue":"8","key":"4529_CR105","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159\u201367.","journal-title":"AIDS"},{"issue":"4","key":"4529_CR106","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/QAI.0000000000002590","volume":"86","author":"K Naidoo","year":"2021","unstructured":"Naidoo K, Mansoor LE, Katz AWK, Garcia M, Kemigisha D, Morar NS, et al. Qualitative perceptions of dapivirine VR adherence and drug level feedback following an open-label extension trial. J Acquir Immune Defic Syndr. 2021;86(4):e90\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"4529_CR107","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s10461-021-03542-z","volume":"26","author":"K Reddy","year":"2022","unstructured":"Reddy K, Mathebula F, Katz A, Luecke E, Tenza S, Palanee-Phillips T, et al. Ring-ing in the future: participant and male partner perspectives regarding future use of the dapivirine vaginal ring for HIV prevention. AIDS Behav. 2022;26(6):1923\u201332.","journal-title":"AIDS Behav"},{"issue":"3","key":"4529_CR108","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/QAI.0000000000002028","volume":"81","author":"A van der Straten","year":"2019","unstructured":"van der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K, Scheckter R, et al. First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring. J Acquir Immune Defic Syndr. 2019;81(3):304\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"4529_CR109","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1007\/s10461-022-03596-7","volume":"26","author":"X Zhao","year":"2022","unstructured":"Zhao X, Milford C, Smit J, Zulu B, Boyd P, Malcolm RK, et al. Color, scent and size: exploring women\u2019s preferences around design characteristics of drug-releasing vaginal rings. AIDS Behav. 2022;26(9):2954\u201368.","journal-title":"AIDS Behav"},{"issue":"2","key":"4529_CR110","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/QAI.0000000000003119","volume":"92","author":"NS Morar","year":"2023","unstructured":"Morar NS, Mansoor LE, Naidoo K, Katz AWK, Garcia M, Duma C, et al. Male partner opinions of the dapivirine vaginal ring used during an open-label extension HIV prevention trial in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2023;92(2):127\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4529_CR111","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/09540121.2023.2198187","volume":"36","author":"EN Browne","year":"2024","unstructured":"Browne EN, Torjesen K, Mirembe BG, Palanee-Phillips T, Jeenarain N, Chitukuta M, et al. Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex. AIDS Care. 2024;36(1):80\u20136.","journal-title":"AIDS Care"},{"issue":"8","key":"4529_CR112","doi-asserted-by":"publisher","first-page":"e25170","DOI":"10.1002\/jia2.25170","volume":"21","author":"EA Krogstad","year":"2018","unstructured":"Krogstad EA, Atujuna M, Montgomery ET, Minnis A, Ndwayana S, Malapane T, et al. Perspectives of South African youth in the development of an implant for HIV prevention. J Int AIDS Soc. 2018;21(8):e25170.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"4529_CR113","doi-asserted-by":"publisher","first-page":"e25528","DOI":"10.1002\/jia2.25528","volume":"23","author":"AM Minnis","year":"2020","unstructured":"Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, et al. Preferences for long-acting pre-exposure prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020;23(6):e25528.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"4529_CR114","doi-asserted-by":"publisher","first-page":"e25408","DOI":"10.1002\/jia2.25408","volume":"22","author":"EE Tolley","year":"2019","unstructured":"Tolley EE, Li S, Zangeneh SZ, Atujuna M, Musara P, Justman J, et al. Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076). J Int AIDS Soc. 2019;22(10):e25408.","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"4529_CR115","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s10461-020-02808-2","volume":"24","author":"EE Tolley","year":"2020","unstructured":"Tolley EE, Zangeneh SZ, Chau G, Eron J, Grinsztejn B, Humphries H, et al. Acceptability of long-acting injectable cabotegravir (CAB LA) in HIV-uninfected individuals: HPTN 077. AIDS Behav. 2020;24(9):2520\u201331.","journal-title":"AIDS Behav"},{"issue":"8","key":"4529_CR116","doi-asserted-by":"publisher","first-page":"e0290568","DOI":"10.1371\/journal.pone.0290568","volume":"18","author":"A Ismail","year":"2023","unstructured":"Ismail A, Magni S, Katahoire A, Ayebare F, Siu G, Semitala F, et al. Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology. PLoS ONE. 2023;18(8):e0290568.","journal-title":"PLoS ONE"},{"key":"4529_CR117","doi-asserted-by":"publisher","first-page":"1125159","DOI":"10.3389\/frph.2023.1125159","volume":"5","author":"SG Gachigua","year":"2023","unstructured":"Gachigua SG, Karuga R, Ngunjiri A, Jarrahian C, Coffey PS, Kilbourne-Brook M, et al. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya. Front Reprod Health. 2023;5:1125159.","journal-title":"Front Reprod Health"},{"issue":"5","key":"4529_CR118","doi-asserted-by":"publisher","first-page":"e0285711","DOI":"10.1371\/journal.pone.0285711","volume":"18","author":"S Nkomo","year":"2023","unstructured":"Nkomo S, Makoni W, Shapley-Quinn MK, Luecke E, Mbatsane E, Manenzhe K, et al. Prospective acceptability of a multipurpose technology (MPT) implant in preclinical development to prevent HIV and unplanned pregnancy: qualitative insights from women end users and health care providers in South Africa and Zimbabwe. PLoS ONE. 2023;18(5):e0285711.","journal-title":"PLoS ONE"},{"issue":"1","key":"4529_CR119","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1186\/s12889-023-16904-0","volume":"23","author":"P Mataboge","year":"2023","unstructured":"Mataboge P, Mthimkhulu N, Kutywayo A, Martin CE, Mazibuko M, Kwatsha K, et al. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa. BMC Public Health. 2023;23(1):2090.","journal-title":"BMC Public Health"},{"issue":"7","key":"4529_CR120","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1007\/s10461-020-03134-3","volume":"25","author":"MCD Stoner","year":"2021","unstructured":"Stoner MCD, Rucinski KB, Giovenco D, Gill K, Morton JF, Bekker LG, et al. Trajectories of PrEP adherence among young women aged 16 to 25 in Cape Town, South Africa. AIDS Behav. 2021;25(7):2046\u201353.","journal-title":"AIDS Behav"},{"issue":"7","key":"4529_CR121","doi-asserted-by":"publisher","first-page":"e25957","DOI":"10.1002\/jia2.25957","volume":"25","author":"LE Mansoor","year":"2022","unstructured":"Mansoor LE, Lewis L, Naicker CL, Harkoo I, Dawood H, Naidoo K, et al. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa. J Int AIDS Soc. 2022;25(7):e25957.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"4529_CR122","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/QAI.0000000000002876","volume":"89","author":"JE Haberer","year":"2022","unstructured":"Haberer JE, Mugo N, Bukusi EA, Ngure K, Kiptinness C, Oware K, et al. Understanding pre-exposure prophylaxis adherence in young women in Kenya. J Acquir Immune Defic Syndr. 2022;89(3):251\u201360.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4529_CR123","doi-asserted-by":"publisher","first-page":"113600","DOI":"10.1016\/j.socscimed.2020.113600","volume":"270","author":"F Scorgie","year":"2021","unstructured":"Scorgie F, Khoza N, Delany-Moretlwe S, Velloza J, Mangxilana N, Atujuna M, et al. Narrative sexual histories and perceptions of HIV risk among young women taking PrEP in southern Africa: findings from a novel participatory method. Soc Sci Med. 2021;270:113600.","journal-title":"Soc Sci Med"},{"key":"4529_CR124","doi-asserted-by":"publisher","first-page":"637869","DOI":"10.3389\/frph.2021.637869","volume":"3","author":"K Ngure","year":"2021","unstructured":"Ngure K, Thuo N, Ogello V, Kiptinness C, Kamolloh K, Burns BFO, et al. Dynamic perceived HIV risk and sexual behaviors among young women enrolled in a PrEP trial in Kenya: a qualitative study. Front Reprod Health. 2021;3:637869.","journal-title":"Front Reprod Health"},{"issue":"11","key":"4529_CR125","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jama.2024.0464","volume":"331","author":"J Marrazzo","year":"2024","unstructured":"Marrazzo J, Tao L, Becker M, Leech AA, Taylor AW, Ussery F, et al. HIV preexposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate among Cisgender women. JAMA. 2024;331(11):930\u20137.","journal-title":"JAMA"},{"key":"4529_CR126","unstructured":"Ngure K. Choice and adherence to dapivirine ring or oral PrEP by young African women in REACH. Conference for retroviruses and opportunistic infections (CROI); Virtual 20222022. 2022"},{"key":"4529_CR127","unstructured":"Torjesen K, Irungu E. The CATALYST Study Protocol Version 2.0. 2023; https:\/\/www.prepwatch.org\/wp-content\/uploads\/2023\/10\/CATALYST-Study-Protocol.pdf."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04529-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-024-04529-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04529-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:05:51Z","timestamp":1737079551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-024-04529-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4529"],"URL":"https:\/\/doi.org\/10.1007\/s10461-024-04529-2","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"6 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial or nonfinancial interests to disclose that are directly or indirectly related to the work submitted for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This paper presents results of a systematic review; thus, no ethics review was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}